Ambea reported second-quarter net sales of SEK 4.39 billion, exceeding the consensus estimate of SEK 4.32 billion from three analysts and representing a 7% increase compared with the same period a year earlier.
The company disclosed adjusted EBITA of SEK 397 million for the quarter and earnings per share of SEK 2.13. On other profitability measures, EBIT reached SEK 353 million, while EBITA was reported at SEK 378 million.
Management attributed the quarter's top- and bottom-line improvement primarily to higher occupancy rates across its care units, which supported both revenue and earnings growth. In addition, Ambea highlighted operational improvements in Norway and Denmark as contributors to its stronger performance during the quarter.
Expansion activities also played a role in the quarter's results. The company said ongoing growth across the Nordic region - including the opening of new care units and acquisitions - helped drive additional revenue in the period.
In a strategic move to deepen its Nordic footprint, Ambea announced a recommended public offer to acquire Humana. The company characterized the move as aimed at strengthening its presence in the region.
Ambea did not provide specific financial guidance for the current quarter or for the full year, leaving near-term expectations unspecified.
Context and implications
The reported beat on net sales and the positive adjusted EBITA figure reflect a quarter in which utilisation of the company's care units improved and operational initiatives in key markets produced measurable benefit. The combination of organic expansion through new unit openings and growth by acquisition supported the revenue increase reported in the period.
What the company reported - at a glance
- Net sales: SEK 4.39 billion - up 7% year-on-year; consensus SEK 4.32 billion from three analysts.
- Adjusted EBITA: SEK 397 million.
- EBIT: SEK 353 million; EBITA: SEK 378 million.
- Earnings per share: SEK 2.13.
- Strategic action: recommended public offer to acquire Humana announced.
- Guidance: no specific financial guidance provided for the quarter or full year.